{"transactions":[{"id":1306439,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-08T16:33:22.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":60975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date."}],"balance_after":598622,"source":{"system":"sec-edgar","filing":"0001801170-25-000015","document":"wk-form4_1736371994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000180117025000015/wk-form4_1736371994.xml","form_type":"4"}},{"id":1685334,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-05T16:23:00.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":206185,"price":0.97,"value":199999.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date."}],"balance_after":537647,"source":{"system":"sec-edgar","filing":"0001801170-24-000026","document":"wk-form4_1704489768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000180117024000026/wk-form4_1704489768.xml","form_type":"4"}},{"id":2062022,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-05T16:35:31.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":176991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock of Clover Health Investments, Corp. (the \"Company\") underlying a time-based restricted stock unit award (\"RSUs\"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date."}],"balance_after":331462,"source":{"system":"sec-edgar","filing":"0001628280-23-000468","document":"wf-form4_167295450617790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828023000468/wf-form4_167295450617790.xml","form_type":"4"}},{"id":2151174,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-09-26T18:00:28.000Z","date":"2022-09-22","kind":"exercise","acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"shares","element":"transactionShares","label":"F3","text":"The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27100},"source":{"system":"sec-edgar","filing":"0001628280-22-025505","document":"wf-form4_166422960816234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022025505/wf-form4_166422960816234.xml","form_type":"4"}},{"id":2151173,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-26T18:00:28.000Z","date":"2022-09-22","kind":"grant","acquired":true,"shares":20271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date."}],"balance_after":154471,"source":{"system":"sec-edgar","filing":"0001628280-22-025505","document":"wf-form4_166422960816234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022025505/wf-form4_166422960816234.xml","form_type":"4"}},{"id":2151172,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-26T18:00:28.000Z","date":"2022-09-22","kind":"exercise","acquired":true,"shares":27100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":134200,"source":{"system":"sec-edgar","filing":"0001628280-22-025505","document":"wf-form4_166422960816234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022025505/wf-form4_166422960816234.xml","form_type":"4"}},{"id":2332979,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-15T08:03:39.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":80000,"price":3.1009,"value":248072.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $3.085 to $3.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":107100,"source":{"system":"sec-edgar","filing":"0001628280-22-006156","document":"wf-form4_164734580175403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022006156/wf-form4_164734580175403.xml","form_type":"4"}},{"id":2437540,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-01-11T21:22:24.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":27100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date."}],"balance_after":27100,"derivative":{"exercise_date":"2022-01-07","underlying":"Class A Common Stock","underlying_shares":27100},"source":{"system":"sec-edgar","filing":"0001628280-22-000724","document":"wf-form4_164195413048020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022000724/wf-form4_164195413048020.xml","form_type":"4"}},{"id":2437539,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-11T21:22:24.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":27100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27100,"source":{"system":"sec-edgar","filing":"0001628280-22-000724","document":"wf-form4_164195413048020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000162828022000724/wf-form4_164195413048020.xml","form_type":"4"}},{"id":2755512,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-04-06T12:43:09.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":54200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date."}],"balance_after":54200,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54200},"source":{"system":"sec-edgar","filing":"0001209191-21-025578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919121025578/doc4.xml","form_type":"4"}},{"id":2997353,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":185121,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997352,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":35887,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997351,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":1743319,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F18","text":"Includes 763,507 RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997350,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":2488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F17","text":"Represents restricted stock units (\"RSUs\") voluntarily forfeited to the Issuer."}],"balance_after":1743319,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997349,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":173041,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire Ventures Fund L.P. and 7wire Ventures Wanxiang Strategic Fund I, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":185121,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997348,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":27106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents the receipt of shares pursuant to a pro rata in-kind distribution by 7wire Ventures Fund L.P."}],"balance_after":1745807,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997347,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-30","kind":"other","acquired":false,"shares":940788,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P. without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":35887,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997346,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-29","kind":"other","acquired":true,"shares":25468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire Ventures LLC - Series Livongo D and 7wire Ventures LLC - Series Livongo E."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F12","text":"Includes 210 shares acquired under the Livongo Health, Inc. 2019 Employee Stock Purchase Plan on October 28, 2020."}],"balance_after":1718701,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997345,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":195277,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997344,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":176361,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997343,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":109748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997342,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":1185097,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares were held of record by 7wire Ventures LLC - Series EosHealth. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997341,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-10-16","kind":"gift","acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1693023,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":2997340,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T17:20:38.000Z","date":"2020-09-11","kind":"other","acquired":true,"shares":12080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares pursuant to a pro rata in-kind distribution by 7wire Ventures Wanxiang Strategic Fund I, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":12080,"source":{"system":"sec-edgar","filing":"0001639225-20-000063","document":"wf-form4_160409282066773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000163922520000063/wf-form4_160409282066773.xml","form_type":"4"}},{"id":3029878,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-16T18:15:05.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":23,"price":124.4602,"value":2862.5846,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.46 to $124.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures Fund, L.P., or 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":976675,"source":{"system":"sec-edgar","filing":"0001209191-20-050762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050762/doc4.xml","form_type":"4"}},{"id":3031138,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":true,"shares":17524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":1828023,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3031137,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":312511,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P., or 7wire LP, without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":976698,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3031136,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":65081,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":195277,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3031135,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":58773,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":176361,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3031134,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":36576,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":109748,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3031133,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-15T16:55:54.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":395025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1185097,"source":{"system":"sec-edgar","filing":"0001209191-20-050490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120050490/doc4.xml","form_type":"4"}},{"id":3037386,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-04T21:12:26.000Z","date":"2020-09-03","kind":"sale","acquired":false,"shares":84132,"price":124.5,"value":10474434.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020 (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In addition, in connection with the Merger the reporting person entered into a voting agreement with Teladoc and certain other stockholders of the Issuer party thereto (the \"Voting Agreement\"), pursuant to which, subject to certain exceptions, the reporting person agreed to vote all shares of the Issuer's common stock held by the reporting person in favor of the approval of the Merger. The sales reported on this form are expressly permitted and contemplated by the Voting Agreement, which permits the reporting person to sell or transfer a number of shares of the Issuer's common stock equivalent to such number of shares that would have been sold had the Trading Plan remained in effect. Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock directly held immediately prior to such sales."}],"balance_after":1810499,"source":{"system":"sec-edgar","filing":"0001209191-20-049681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120049681/doc4.xml","form_type":"4"}},{"id":3044466,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-28T16:17:32.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":5734,"price":132.53,"value":759927.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 446 shares acquired under the Livongo Health, Inc. 2019 Employee Stock Purchase Plan on May 15, 2020."}],"balance_after":1894631,"source":{"system":"sec-edgar","filing":"0001209191-20-048623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120048623/doc4.xml","form_type":"4"}},{"id":3077618,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-22T17:23:11.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":48565,"price":113.83,"value":5528153.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":1899919,"source":{"system":"sec-edgar","filing":"0001209191-20-043339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120043339/doc4.xml","form_type":"4"}},{"id":3094985,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-01T19:34:17.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":52,"price":74.76,"value":3887.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by 7wire Ventures Fund, L.P., or 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1289209,"source":{"system":"sec-edgar","filing":"0001209191-20-039946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120039946/doc4.xml","form_type":"4"}},{"id":3097445,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":true,"shares":21567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":1948484,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3097444,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":384629,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P., or 7wire LP, without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1289261,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3097443,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":80099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":260358,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3097442,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":72337,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":235134,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3097441,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":45017,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":146324,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3097440,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:55:25.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":486183,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1580122,"source":{"system":"sec-edgar","filing":"0000899243-20-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320017836/doc4.xml","form_type":"4"}},{"id":3131897,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-28T18:00:33.000Z","date":"2020-05-26","kind":"tax_withholding","acquired":false,"shares":3966,"price":55,"value":218130.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":1926917,"source":{"system":"sec-edgar","filing":"0001209191-20-032696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120032696/doc4.xml","form_type":"4"}},{"id":3145138,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-18T18:55:17.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":1322,"price":59.03,"value":78037.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs."}],"balance_after":1930883,"source":{"system":"sec-edgar","filing":"0001209191-20-030239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120030239/doc4.xml","form_type":"4"}},{"id":3145137,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-18T18:55:17.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":69023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in 16 equal quarterly installments beginning on August 25, 2020."}],"balance_after":1932205,"source":{"system":"sec-edgar","filing":"0001209191-20-030239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120030239/doc4.xml","form_type":"4"}},{"id":3172273,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-21T16:46:31.000Z","date":"2020-04-20","kind":"tax_withholding","acquired":false,"shares":1322,"price":37.86,"value":50050.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":1863182,"source":{"system":"sec-edgar","filing":"0001209191-20-025281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120025281/doc4.xml","form_type":"4"}},{"id":3177767,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":16174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":1864504,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177766,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":288469,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro rata in-kind distribution by 7wire LP without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1673890,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177765,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":802458,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents the receipt of shares by 7wire LP pursuant to pro rata in-kind distributions by 7wire Ventures, LLC - Series EosHealth and 7wire Ventures LLC - Series Livongo C without consideration to its partners (including 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1962359,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177764,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":60071,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":340457,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177763,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":54247,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":307471,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177762,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":93790,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners (including 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":191341,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177761,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":1307682,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners (including 7wire Ventures Fund, L.P., or 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":2066305,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177760,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-03-06","kind":"gift","acquired":false,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1848330,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3177759,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T19:22:21.000Z","date":"2020-02-20","kind":"gift","acquired":false,"shares":380,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1852520,"source":{"system":"sec-edgar","filing":"0000899243-20-010679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924320010679/doc4.xml","form_type":"4"}},{"id":3200378,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-19T18:00:56.000Z","date":"2020-03-18","kind":"tax_withholding","acquired":false,"shares":1322,"price":23,"value":30406.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":1852900,"source":{"system":"sec-edgar","filing":"0001209191-20-020322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120020322/doc4.xml","form_type":"4"}},{"id":3220085,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T18:08:00.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":13347,"price":27.9447,"value":372977.9109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.80 to $28.04, inclusive."}],"balance_after":1854222,"source":{"system":"sec-edgar","filing":"0001209191-20-017444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120017444/doc4.xml","form_type":"4"}},{"id":3220084,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T18:08:00.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":12606,"price":27.5249,"value":346978.8894,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.80 to $27.79, inclusive."}],"balance_after":1867569,"source":{"system":"sec-edgar","filing":"0001209191-20-017444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120017444/doc4.xml","form_type":"4"}},{"id":3220083,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T18:08:00.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":1547,"price":26.3577,"value":40775.3619,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.72 to $26.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":1880175,"source":{"system":"sec-edgar","filing":"0001209191-20-017444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120017444/doc4.xml","form_type":"4"}},{"id":3242465,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-28T16:30:17.000Z","date":"2020-02-28","kind":"purchase","acquired":true,"shares":4065,"price":12,"value":48780.0,"ownership":{"direct":true},"balance_after":40304,"source":{"system":"sec-edgar","filing":"0001567619-20-005132","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000156761920005132/doc1.xml","form_type":"4"}},{"id":3262533,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-19T17:30:59.000Z","date":"2020-02-18","kind":"tax_withholding","acquired":false,"shares":818,"price":26.93,"value":22028.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":1881722,"source":{"system":"sec-edgar","filing":"0001209191-20-010723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120010723/doc4.xml","form_type":"4"}},{"id":3303841,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-23T20:51:11.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":102325,"price":28.9,"value":2957192.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":1882540,"source":{"system":"sec-edgar","filing":"0001209191-20-004764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000120919120004764/doc4.xml","form_type":"4"}},{"id":3387242,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-28T16:33:31.000Z","date":"2019-10-28","kind":"disposition_to_issuer","acquired":false,"shares":5214,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.98,"expiration_date":"2022-05-16","underlying":"Common Stock","underlying_shares":5214},"source":{"system":"sec-edgar","filing":"0001453814-19-000149","document":"wf-form4_157229477150358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381419000149/wf-form4_157229477150358.xml","form_type":"4"}},{"id":3387241,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-28T16:33:31.000Z","date":"2019-10-28","kind":"disposition_to_issuer","acquired":false,"shares":4494,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option."}],"balance_after":0,"derivative":{"exercise_price":11.5,"expiration_date":"2021-05-31","underlying":"Common Stock","underlying_shares":4494},"source":{"system":"sec-edgar","filing":"0001453814-19-000149","document":"wf-form4_157229477150358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381419000149/wf-form4_157229477150358.xml","form_type":"4"}},{"id":3387240,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-28T16:33:31.000Z","date":"2019-10-28","kind":"disposition_to_issuer","acquired":false,"shares":28827,"price":92.25,"value":2659290.75,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE (\"DS\"), Dassault Systemes Americas Corp., a Delaware corporation (\"Parent\"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Merger Sub\"), and Medidata Solutions, Inc., a Delaware corporation (the \"Issuer\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share (\"Issuer Common Stock\"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share (\"Issuer Common Stock\"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001453814-19-000149","document":"wf-form4_157229477150358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381419000149/wf-form4_157229477150358.xml","form_type":"4"}},{"id":3453216,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":60000,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares are held of record by 7Wire Ventures Wanxiang Strategic Fund I, LLC, or 7Wire Wanxiang. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Wanxiang. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453215,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":400528,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400528},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453214,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":488683,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":488683},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453213,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":361718,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":361718},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453212,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":250800,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":250800},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453211,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":285131,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":285131},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453210,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":2104,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2104},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453209,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":3506,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3506},"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453208,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":60000,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares are held of record by 7Wire Ventures Wanxiang Strategic Fund I, LLC, or 7Wire Wanxiang. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Wanxiang. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453207,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":400528,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":400528,"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453206,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":361718,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":361718,"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453205,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":285131,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":285131,"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3453204,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T16:32:59.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":745093,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1159901,"source":{"system":"sec-edgar","filing":"0000899243-19-020582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213350/000089924319020582/doc4.xml","form_type":"4"}},{"id":3507473,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T16:55:38.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock. The restrictions will lapse in full on May 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Granted as compensation for services."}],"balance_after":28827,"source":{"system":"sec-edgar","filing":"0001453814-19-000089","document":"wf-form4_155924972328476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381419000089/wf-form4_155924972328476.xml","form_type":"4"}},{"id":3511072,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T15:07:00.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":6098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/23/2019), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date."}],"balance_after":36239,"source":{"system":"sec-edgar","filing":"0001567619-19-012201","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000156761919012201/doc1.xml","form_type":"4"}},{"id":3582391,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T15:00:29.000Z","date":"2019-03-20","kind":"purchase","acquired":true,"shares":4050,"price":17.8,"value":72090.0,"ownership":{"direct":true},"balance_after":30141,"source":{"system":"sec-edgar","filing":"0001567619-19-007451","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000156761919007451/doc1.xml","form_type":"4"}},{"id":3860808,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T17:13:10.000Z","date":"2018-07-26","kind":"sale","acquired":false,"shares":12500,"price":76.16,"value":952000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Such transaction was executed in multiple trades at prices ranging from $75.39 to $77.32. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26028,"source":{"system":"sec-edgar","filing":"0001453814-18-000108","document":"wf-form4_153263957212902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381418000108/wf-form4_153263957212902.xml","form_type":"4"}},{"id":3912397,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-31T16:24:54.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":3025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of restricted stock. The restrictions will lapse in full on May 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Granted as compensation for services."}],"balance_after":38528,"source":{"system":"sec-edgar","filing":"0001453814-18-000088","document":"wf-form4_152779828058021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381418000088/wf-form4_152779828058021.xml","form_type":"4"}},{"id":3912396,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-31T16:24:54.000Z","date":"2018-03-05","kind":"gift","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":35467,"source":{"system":"sec-edgar","filing":"0001453814-18-000088","document":"wf-form4_152779828058021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381418000088/wf-form4_152779828058021.xml","form_type":"4"}},{"id":3917962,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-25T13:05:03.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":2876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/24/2018), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date."}],"balance_after":26091,"source":{"system":"sec-edgar","filing":"0001140361-18-025695","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000114036118025695/doc1.xml","form_type":"4"}},{"id":4062698,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-13T16:46:12.000Z","date":"2017-11-28","kind":"gift","acquired":false,"shares":59,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":35842,"source":{"system":"sec-edgar","filing":"0001453814-18-000006","document":"wf-form5_151855832283551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381418000006/wf-form5_151855832283551.xml","form_type":"5"}},{"id":4062697,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-13T16:46:12.000Z","date":"2017-11-27","kind":"gift","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":35901,"source":{"system":"sec-edgar","filing":"0001453814-18-000006","document":"wf-form5_151855832283551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381418000006/wf-form5_151855832283551.xml","form_type":"5"}},{"id":4298055,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T16:44:23.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of restricted stock. The restrictions will lapse in full on May 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Granted as compensation for services."}],"balance_after":36265,"source":{"system":"sec-edgar","filing":"0001453814-17-000091","document":"wf-form4_149634984881074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381417000091/wf-form4_149634984881074.xml","form_type":"4"}},{"id":4298054,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T16:44:23.000Z","date":"2017-02-14","kind":"gift","acquired":false,"shares":644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":32931,"source":{"system":"sec-edgar","filing":"0001453814-17-000091","document":"wf-form4_149634984881074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381417000091/wf-form4_149634984881074.xml","form_type":"4"}},{"id":4302133,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T10:56:39.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units that vest on 5/25/2018."}],"balance_after":23215,"source":{"system":"sec-edgar","filing":"0001140361-17-022650","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000114036117022650/doc1.xml","form_type":"4"}},{"id":4448816,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T17:41:11.000Z","date":"2016-12-16","kind":"gift","acquired":false,"shares":742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":33575,"source":{"system":"sec-edgar","filing":"0001453814-17-000008","document":"wf-form5_148711202004438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381417000008/wf-form5_148711202004438.xml","form_type":"5"}},{"id":4448815,"issuer":{"id":154211,"kind":"organization","name":"Medidata Solutions, Inc.","symbol":"MDSO"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T17:41:11.000Z","date":"2016-12-15","kind":"gift","acquired":false,"shares":992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona fide gift by the Reporting Person for no consideration."}],"balance_after":34317,"source":{"system":"sec-edgar","filing":"0001453814-17-000008","document":"wf-form5_148711202004438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453814/000145381417000008/wf-form5_148711202004438.xml","form_type":"5"}},{"id":4566159,"issuer":{"id":125776,"kind":"organization","name":"TIVITY HEALTH, INC.","symbol":"TVTY"},"owners":[{"id":84281,"kind":"person","name":"SHAPIRO LEE","position":1,"cik":"0001213350","reported_name":"SHAPIRO LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-07T14:00:26.000Z","date":"2016-11-04","kind":"purchase","acquired":true,"shares":1266,"price":19.53,"value":24724.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $19.50 to $19.55. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":20203,"source":{"system":"sec-edgar","filing":"0001140361-16-085028","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704415/000114036116085028/doc1.xml","form_type":"4"}}]}